These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27816027)

  • 1. Cognitive impairment in patients with Parkinson's disease: A 30-month follow-up study.
    Chen L; Yu C; Zhang N; Liu J; Liu W
    Clin Neurol Neurosurg; 2016 Dec; 151():65-69. PubMed ID: 27816027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of cognitive impairment in an early stage Parkinson's disease cohort.
    Hu MT; Szewczyk-Królikowski K; Tomlinson P; Nithi K; Rolinski M; Murray C; Talbot K; Ebmeier KP; Mackay CE; Ben-Shlomo Y
    Mov Disord; 2014 Mar; 29(3):351-9. PubMed ID: 24395708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.
    Keener AM; Paul KC; Folle A; Bronstein JM; Ritz B
    J Parkinsons Dis; 2018; 8(2):353-362. PubMed ID: 29843251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
    Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
    Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.
    Mills KA; Schneider RB; Saint-Hilaire M; Ross GW; Hauser RA; Lang AE; Halverson MJ; Oakes D; Eberly S; Litvan I; Blindauer K; Aquino C; Simuni T; Marras C
    Parkinsonism Relat Disord; 2020 Nov; 80():127-132. PubMed ID: 32987359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study.
    Biundo R; Weis L; Bostantjopoulou S; Stefanova E; Falup-Pecurariu C; Kramberger MG; Geurtsen GJ; Antonini A; Weintraub D; Aarsland D
    J Neural Transm (Vienna); 2016 Apr; 123(4):431-8. PubMed ID: 26852137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson's disease.
    Wan Y; Hu W; Gan J; Song L; Wu N; Chen Y; Liu Z
    Brain Behav; 2019 Apr; 9(4):e01219. PubMed ID: 30815987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.
    Nie K; Zhang Y; Wang L; Zhao J; Huang Z; Gan R; Li S; Wang L
    J Clin Neurosci; 2012 Nov; 19(11):1497-500. PubMed ID: 22959678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance of Mini-Mental State Examination, Montreal Cognitive Assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease.
    Scheffels JF; Fröhlich L; Kalbe E; Kessler J
    J Neurol Sci; 2020 May; 412():116735. PubMed ID: 32087430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and Clinician Impressions of Cognitive Impairment in Parkinson's Disease.
    Ngo AB; Smith KM
    J Parkinsons Dis; 2020; 10(4):1695-1698. PubMed ID: 32925096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between retinal nerve fiber layer thickness and cognitive progression in Parkinson's disease: A longitudinal study.
    Zhang JR; Cao YL; Li K; Wang F; Wang YL; Wu JJ; Pei SF; Chen J; Mao CJ; Liu CF
    Parkinsonism Relat Disord; 2021 Jan; 82():92-97. PubMed ID: 33271462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the ASCO classification with the executive function subscores of the Montreal cognitive assessment in patients with postischemic stroke.
    Washida K; Ihara M; Tachibana H; Sekiguchi K; Kowa H; Kanda F; Toda T
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2250-5. PubMed ID: 25174562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1).
    Wilson H; Pagano G; Yousaf T; Polychronis S; De Micco R; Giordano B; Niccolini F; Politis M
    J Neural Transm (Vienna); 2020 Jan; 127(1):51-59. PubMed ID: 31853652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in idiopathic Parkinson's disease.
    Das D; Biswas A; Roy A; Sauerbier A; Bhattacharyya KB
    Neurol India; 2016; 64(3):419-27. PubMed ID: 27147148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montreal Cognitive Assessment in cryptogenic epilepsy patients with normal Mini-Mental State Examination scores.
    Phabphal K; Kanjanasatien J
    Epileptic Disord; 2011 Dec; 13(4):375-81. PubMed ID: 22258041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised.
    Sobreira E; Pena-Pereira MA; Eckeli AL; Sobreira-Neto MA; Chagas MH; Foss MP; Cholerton B; Zabetian CP; Mata IF; Tumas V
    Arq Neuropsiquiatr; 2015 Nov; 73(11):929-33. PubMed ID: 26517216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suitability of the Montreal cognitive assessment versus the mini-mental state examination in detecting vascular cognitive impairment.
    Ihara M; Okamoto Y; Takahashi R
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):737-41. PubMed ID: 22306380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.